Faris Khan is a Cardiology physician. OpenAlex indexes 86 publications with 1,110 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Emile At 42nd St
Omaha, NE 681980001
Telephone
402-559-8888Registry record last updated 28 Aug 2017.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20252 payments
- Boston Scientific CorporationProgram year20252 payments
- Medtronic, Inc.Program year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
54.3%Beta blocker22.4%Metoprolol Succinate45%Metoprolol Tartrate25%Carvedilol18%Sotalol11%Part D≥40 patientsAntiarrhythmic12.1%Dofetilide61%Amiodarone Hcl21%Flecainide Acetate18%Part D≥22 patients+ 7 more classes in this area
Blood & clotting
38.6%Factor Xa inhibitor34.7%Eliquis89%Xarelto11%Part D≥84 patientsVitamin K antagonist2.9%Warfarin Sodium100%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
6.1%SGLT2 inhibitor3.8%Jardiance100%Part D<11 patientsPotassium supplement1.3%Potassium Chloride100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Social Media Marketing and Purchase Intention: Multi-Mediating Engagement, Brand Equity, eWOM, and Trust
Journal of Social & Organizational Matters
2026 - Representation of Women in Atrial Fibrillation Ablation Randomized Controlled Trials: Systematic Review
Journal of the American Heart Association
2025 - Estimating CO2 emissions from international medical electives: a literature review and quantitative analysis
Future Healthcare Journal
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”